The time-course for up- and down-regulation of the cortical 5-hydroxytryptamine (5-HT)2A receptor density predicts 5-HT2A receptor-mediated behavior in the rabbit.

J Pharmacol Exp Ther

Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 N. 15th Street, 8th Floor, NCB, Mail stop 488, Philadelphia, PA 19102, USA.

Published: October 2007


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

5-Hydroxytryptamine (serotonin; 5-HT)2 receptor agonists such as (+/-)-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) injected systemically or directly into frontal cortex, elicit stereotyped head movements that are mediated by 5-HT2A receptors. Chronic administration of 5-HT2A receptor antagonists can produce either a down-regulation, e.g., d-2-bromolysergic acid diethylamide (BOL) or an up-regulation, e.g., alpha-phenyl-10(2-phenylethyl)-4-piperidinemethanol (MDL11,939) of cortical 5-HT2A receptors in the rabbit with no change in the density of the 5-HT2C receptor. We examined the degree to which the time course for the onset and offset of changes in cortical 5-HT2A receptor density was correlated with functional changes as measured by the magnitude of DOI elicited, 5-HT2A receptor-mediated head movements (head bobs). First, the magnitude of DOI-elicited head bobs was measured over 1 to 8 days after chronic BOL (5.8 micromol/kg), MDL11,939 (10 micromol/kg), or vehicle administration. Second, rabbits were injected with BOL, MDL11,939, or vehicle once daily for 8 days, and then, 1 to 8 days after the cessation of drug or vehicle, DOI-elicited head bobs were determined. Samples of frontal cortex were obtained for each animal immediately following behavioral testing, and 5-HT2A receptor density was measured using [3H]ketanserin. Thus, each animal provided a value for receptor density and number of head bobs, and these two measures showed a high degree of correlation between 0.94 for BOL and 0.95 for MDL11,939. This study establishes that the density of 5-HT2A receptors in cortex reflects their functional status.

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.107.121707DOI Listing

Publication Analysis

Top Keywords

5-ht2a receptor
16
receptor density
16
head bobs
16
5-ht2a receptors
12
5-ht2a
9
5-ht2a receptor-mediated
8
frontal cortex
8
head movements
8
cortical 5-ht2a
8
doi-elicited head
8

Similar Publications

Introduction: Studies suggest that serotonin (5-HT) plays an important role in alcohol use disorder (AUD). While several receptor subtypes modulate the role of 5-HT in AUD, evidence suggests that 5-HT and 5-HT receptors may be directly involved in alcohol drinking due to their interaction with the mesolimbic dopaminergic system. The aim of the present study was to investigate the effects of 5-HT and 5-HT antagonists, alone or in combination, on the acquisition and expression (i.

View Article and Find Full Text PDF

Importance: Effective and well-tolerated pharmacotherapies for generalized anxiety disorder (GAD), which is one of the most common psychiatric disorders, are needed.

Objective: To determine the dose-response relationship of MM120 (lysergide D-tartrate) in adults with moderate to severe GAD.

Design, Settings, And Participants: This phase 2b, multicenter, randomized, double-blind, placebo-controlled study enrolled 198 adults aged 18 to 74 years with a primary GAD diagnosis who presented with moderate to severe symptoms (defined by a Hamilton Anxiety Rating Scale [HAM-A] score ≥20) and was conducted at 22 outpatient psychiatric research sites in the US from August 2022 to August 2023.

View Article and Find Full Text PDF

Exploring the Effects of Psilocybin on Depression and the Mediating Role of the 5-HT2A Receptor: A Systematic Review.

Acta Neuropsychiatr

September 2025

Department of Developmental and Personality Psychology, Laboratory of Experimental Psychology, Neuroscience, and Behavior (LPNeC), Universidade Federal of Rio Grande do Sul (UFRGS), Brazil.

Background: Major depressive disorder (MDD) is a significant public health concern, and current treatments often have limitations in effectiveness and adherence. Psilocybin, a psychedelic compound found in certain mushrooms, is being explored as a potential treatment for depression. It primarily acts through the serotonin 5-HT2A receptor but interacts with 5-HT1A and 5-HT2C receptors.

View Article and Find Full Text PDF

Objective: To identify pharmacogenetic markers of the effectiveness and safety of sertraline pharmacotherapy at polymorphic loci (-1438G>A, rs6311), (102c>T, rs6313), (1354C/T, rs6314), (rs7997012 G>A) of the gene in patients with mixed anxiety-depressive disorder from the Republic of Bashkortostan.

Material And Methods: The study included 100 patients treated with sertraline. The effectiveness and safety of sertraline therapy in patients were assessed using standardized psychometric scales on the day before the start of therapy and then for 42 days.

View Article and Find Full Text PDF

The 5-hydroxytryptamine 2A receptor (5-HTR) is one of the key targets in the development of novel antidepressants. To develop new antidepressants targeting the 5-HT receptor, this study established a high-throughput screening method for drugs targeting the 5-HT receptor based on the principle of detecting calcium flux signals. The immunofluorescence assay and western blotting were employed to evaluate receptor expression levels in the 5-HTR-CHO cell line.

View Article and Find Full Text PDF